Clinical trials
Feasibility clinical trials
Below are recruiting feasibility clinical trials, each written for real people, not researchers. We’re tracking 796 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06561932Recruiting
Leadless pacemaker for heart failure resynchronization
This trial tests a completely leadless pacemaker (WiSE® CRT) for heart failure patients who need cardiac resynchronization therapy (CRT). It aims to avoid the long-term risks of traditional wires (leads) in the heart.
Birtinya, QueenslandAges 22 years+ - NCT06556693Recruiting
Study of a new device for severe sleep apnea
This study tests if a new device can help people with severe sleep-disordered breathing (like sleep apnea). It may be an option if you have no or well-managed heart failure and are able to follow study procedures.
Scottsdale, ArizonaAges 22 years+ - NCT06558214RecruitingPhase 2
Laser surgery, Optune device, and Keytruda for recurrent glioblastoma
This trial tests a combination of MRI-guided laser surgery, a wearable device (Optune) that sends electric fields to the brain, and an immunotherapy drug (pembrolizumab/Keytruda) for people whose glioblastoma has come back. The goal is to see if this approach is safe and works better than standard treatments.
Gainesville, FloridaAges 18–90 - NCT05698810Recruiting
Study exams practice for upcoming research
This trial checks whether it’s practical and workable to set up study-related exams before planned research. It mainly recruits adults who can consent and be contacted, so the team can prepare future studies smoothly.
GrenobleAges 18 years+ - NCT06548386Recruiting
A new device to check for air leaks after lung surgery
This study is testing a new tool that checks for air leaks in the chest tube placed after lung surgery. An air leak can slow down recovery, and this device may help doctors detect it more accurately.
Evanston, IllinoisAges 18 years+ - NCT06543277Recruiting
Nerve stimulation with hand therapy for spinal cord injury
This trial tests a safe, non-invasive nerve stimulation on the ear combined with arm and hand therapy to see if it can improve movement and function for people with neck-level spinal cord injury who still have some hand ability.
Houston, TexasAges 18 years+ - NCT06540196Recruiting
AI tool to predict lung cancer spread during ultrasound staging
This trial tests an artificial intelligence platform that helps doctors predict if lymph nodes in the chest contain cancer during a routine ultrasound procedure. It aims to make staging more accurate for people with suspected or confirmed non-small cell lung cancer.
Hamilton, OntarioAges 18 years+ - NCT06520566Recruiting
Holistic Care Partner Program Study for Black Mothers
This study tests whether a new program called the Holistic Care Partner program is easy to use and helpful for Black mothers. It focuses on mothers getting pregnancy care at NYU Langone Health in New York.
New York, New YorkAges 18 years+ - NCT06531083Recruiting
Early monitoring and physical therapy to prevent jaw stiffness after radiation
This study tests whether a program of early monitoring and physical therapy can help prevent or reduce jaw stiffness (trismus) after radiation therapy for head and neck cancer. It is for patients who are about to start radiation and want to keep their jaw working well.
Edmonton, AlbertaAges 18 years+ - NCT06520020Recruiting
Spinal cord stimulation for spinal cord injury
This study tests whether a gentle electrical stimulation applied to the skin over the spine can be safely used for people with spinal cord injury. If you have had a surgery to stabilize your spine, this stimulation could help with recovery.
Lexington, KentuckyAges 18–80 - NCT06526858Recruiting
Laparoscopic kidney nerve treatment for resistant hypertension
This study tests a new treatment called HyperQure RDN, a laparoscopic (keyhole) surgery that targets nerves near the kidneys to lower blood pressure in people with resistant hypertension. If you have tried multiple medications but your blood pressure is still high, this procedure might offer an alternative approach.
Orange, CaliforniaAges 22–80 - NCT05903430Recruiting
MRI-guided focused radiation for limited spread cancer
This feasibility study tests whether MRI-guided, highly focused radiation can be safely delivered to tumors in the abdomen or central lung. It may help patients with a small number of metastases by aiming treatment more precisely and gathering detailed outcomes for future care.
Manchester, United KingdomAges 18 years+ - NCT06507748Recruiting
Measuring pain with a finger device in NF1
This study tests a new way to measure pain and other sensations in people with NF1 using a device that clips onto a finger or toe. The device looks at how your pupil reacts to mild pulses, which may help doctors better understand your pain.
Washington D.C., District of ColumbiaAges 1–120 - NCT06510556Recruiting
Testing a new mapping and ablation system for AFib
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
BrusselsAges 18 years+ - NCT06512558Recruiting
Using augmented reality for breast cancer surgery planning
This trial tests whether augmented reality can help doctors locate tumors that cannot be felt during breast cancer surgery. If you are having surgery for a non-palpable breast lesion and need an MRI, you may be able to join.
Clermont-FerrandAges 18–100 - NCT06511934Recruiting
BrainGate2 tablet trial for tetraplegia
This trial tests a brain-computer interface (BrainGate2) system for people with tetraplegia (paralysis of all four limbs). It aims to see if the system can help you control a tablet computer using only your brain signals. This is for people who were already in the BrainGate2 study.
Boston, MassachusettsAges 18–80 - NCT06474546Recruiting
Diet intervention feasibility study for juvenile arthritis
This trial tests whether a special diet can help children and teens with juvenile arthritis. If you join, you will follow the diet and provide stool samples so the researchers can see how it affects your gut and arthritis.
Winnipeg, ManitobaAges 8–18 - NCT06462170Recruiting
Measuring insulin production in type 2 diabetes
This study tests how well your body makes insulin by having you drink a Boost shake and checking your blood. It's designed for people with type 2 diabetes who are not yet on insulin.
Ottawa, OntarioAges 18 years+ - NCT06447948Recruiting
Keeping active after fall prevention classes
This study tests a program to help older adults keep exercising after finishing a fall prevention class. It aims to see if the program is practical and helps people stay steady and active.
Newcastle upon Tyne, Tyne and WearAges Any age - NCT06452407Recruiting
App for managing endometriosis symptoms and treatment
This trial tests a new app called elleFA to help track endometriosis symptoms and treatment. If you are being treated for endometriosis at the McGill University Health Centre, the app may make it easier to manage your care from home.
Montreal, QuebecAges 18 years+ - NCT06459271Recruiting
CALM counseling for advanced ovarian cancer
This trial is testing a type of counseling called CALM (Managing Cancer and Living Meaningfully) for people with advanced ovarian cancer. It aims to see if this support program is helpful and practical for patients.
Toronto, OntarioAges 18 years+ - NCT06431269Recruiting
Screening for developmental disorders in children with heart disease
This study is looking for children aged 1 to 5 years who have congenital heart disease and had heart surgery or a procedure in their first year. A special nurse will check for early signs of developmental delays, to see if this kind of screening is helpful for these children.
MontpellierAges 1–5 - NCT06427603Recruiting
Sit less and move more for older adults
This study tests a program to help older adults who sit a lot and are overweight to sit less and move more, using a smartphone app to track activity.
Ho Man TinAges 65 years+ - NCT06430684RecruitingEarly Phase 1
SGLT2 inhibitor trial for children with kidney disease
This trial tests a medication called SGLT2 inhibitor (a type of diabetes drug that may also help protect the kidneys) in children with chronic kidney disease. It aims to see if the drug is safe and easy to use in children ages 2–18 with moderate to severe kidney problems.
Chicago, IllinoisAges 12–25
Hear when a new Feasibility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for feasibility?
- Yes. Clin2 currently lists 796 recruiting feasibility studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a feasibility trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a feasibility trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.